Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

N Engl J Med. 2021 Jul 8;385(2):187-189. doi: 10.1056/NEJMc2104974. Epub 2021 May 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / diagnosis
  • COVID-19 / mortality
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / immunology
  • Case-Control Studies
  • Cohort Studies
  • Humans
  • Immunogenicity, Vaccine*
  • Polymerase Chain Reaction
  • Qatar / epidemiology
  • SARS-CoV-2*
  • Treatment Outcome

Substances

  • COVID-19 Vaccines
  • BNT162 vaccine